Vergent Bioscience
Vergent Bioscience is a clinical-stage biotechnology company based in Minneapolis, MN, focused on enhancing the effectiveness of minimally invasive and robotic-assisted cancer surgeries. Their leading compound, abenacianine for injection (VGT-309), is a tumor-targeted fluorescent imaging agent designed to enable surgeons to identify and remove previously undetected tumors in real-time during procedures.
Committed to improving surgical outcomes for patients with solid tumors, Vergent Bioscience combines innovative technology with rigorous scientific principles. The company aims to become a global leader in intraoperative tumor visualization, working closely with surgeons to maximize the curative potential of cancer surgery.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
